DrugDashboards

Quinapril

Quinapril Hydrochloride · QUINAPRIL HYDROCHLORIDE 5 mg/1 · Tablet, Film Coated · Oral · Aurobindo Pharma Limited

NDC 65862-0617-90 · 90 TABLET, FILM COATED in 1 BOTTLE · ANDA · View full market →

The short version

Just 3 companies supply this market — thin enough that a single exit would be felt immediately. The price is down 26% over the past year, to $0.0753 per unit. It is in shortage right now — FDA lists the reason as “discontinuation of the manufacture of the drug”.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.2$0.4$0.6Nov 2013Jan 2023$0.0753
111 price points · per · last surveyed Invalid Date · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

WAC per package, as filed
$15.00
Reported to Texas DSHS · 2026 annual filing · Aurobindo Pharma Usa, Inc.

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2022)

$247
46 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA202725
TE code
AB
Approval date
Apr 29, 2013
Patents / exclusivity
None on file

Shortage history

  • In shortage now — Quinapril Hydrochloride, Tablet, 10 mg (NDC 65862-618-90)Jan 19, 2023
    Discontinuation of the manufacture of the drug
    month 44 — 3× the typical 14-month oral solid shortage · model puts 31% odds it resolves within 6 months
  • In shortage now — Quinapril Hydrochloride, Tablet, 40 mg (NDC 65862-620-90)Jan 19, 2023
    Discontinuation of the manufacture of the drug
    month 44 — 3× the typical 14-month oral solid shortage · model puts 31% odds it resolves within 6 months
  • In shortage now — Quinapril Hydrochloride, Tablet, 5 mg (NDC 65862-617-90)Jan 19, 2023
    Discontinuation of the manufacture of the drug
    month 44 — 3× the typical 14-month oral solid shortage · model puts 31% odds it resolves within 6 months

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Quinapril Hydrochloride (Tablet, Film Coated)

LabelerStrengthFirst seenLast seen
Aurobindo Pharma LimitedQUINAPRIL HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 3, 2026
Aurobindo Pharma LimitedQUINAPRIL HYDROCHLORIDE 20 mg/1Jul 15, 2026Sep 3, 2026
Aurobindo Pharma LimitedQUINAPRIL HYDROCHLORIDE 40 mg/1Jul 15, 2026Sep 3, 2026
Aurobindo Pharma LimitedQUINAPRIL HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 3, 2026
Bryant Ranch PrepackQUINAPRIL HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Proficient Rx LPQUINAPRIL HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Quinapril — NDC 65862-0617-90," retrieved September 3, 2026, https://drugdashboards.com/drug/65862061790.

Free to cite with attribution — see how the data is put together.